Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.71 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.71 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.71 |
| ▸ | PPARG | P37231 | 7/20 | 0.71 |
| ▸ | PPARD | Q03181 | 7/20 | 0.71 |
| ▸ | PPARA | Q07869 | 7/20 | 0.71 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.71 |
| ▸ | TSHR | P16473 | 4/20 | 0.71 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.71 |
| ▸ | TLR2 | O60603 | 2/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.71 |
| ▸ | FABP4 | P15090 | 2/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.71 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.71 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.71 |
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | ESR1 | P03372 | 1/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.71 |
| ▸ | PDE4A | P27815 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27894694 | 1.00 | FFAR4 (0.71) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL27212316 | 1.00 | FFAR4 (0.71) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL1985671 | 1.00 | FFAR4 (0.71) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL27212313 | 1.00 | FFAR4 (0.71) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL29144637 | 1.00 | FFAR4 (0.71) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL25195763 | 0.98 | FFAR4 (0.74) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL10780484 | 0.98 | FFAR4 (0.74) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL5710166 | 0.98 | FFAR4 (0.74) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL3027238 | 0.98 | FFAR4 (0.68) | FFAR4FFAR1GPR84PPARGPPARD | |
| SCHEMBL10592536 | 0.98 | FFAR4 (0.74) | FFAR4FFAR1GPR84PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023188830-A1 | LIPID NANOPARTICLES | 国立大学法人北海道大学 | 2023-10-05 | — | — | WO | claimed |
| US-20250205362-A1 | LIPID NANOPARTICLES | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2025-06-26 | — | — | US | disclosed |
| US-20250177559-A1 | BRANCHED LIPID CHARGE-ALTERING RELEASABLE TRANSPORTERS FOR NUCLEIC ACID DELIVERY | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2025-06-05 | — | — | US | disclosed |
| CN-119698302-A | Lipid nanoparticles | 国立大学法人北海道大学 | 2025-03-25 | — | — | CN | disclosed |
| EP-4501359-A1 | LIPID NANOPARTICLES | National University Corporation Hokkaido University (JP) | 2025-02-05 | — | — | EP | disclosed |
| EP-4489786-A1 | BRANCHED LIPID CHARGE-ALTERING RELEASABLE TRANSPORTERS FOR NUCLEIC ACID DELIVERY | The Board of Trustees of the Leland Stanford Junior University (US) | 2025-01-15 | — | — | EP | disclosed |
| WO-2024102730-A1 | LIPIDS AND NANOPARTICLE COMPOSITIONS FOR DELIVERING POLYNUCLEOTIDES | ORNA THERAPEUTICS, INC. (US) | 2024-05-16 | — | — | WO | disclosed |
| WO-2023188830-A1 | LIPID NANOPARTICLES | 国立大学法人北海道大学 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023172885-A1 | BRANCHED LIPID CHARGE-ALTERING RELEASABLE TRANSPORTERS FOR NUCLEIC ACID DELIVERY | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2023-09-14 | — | — | WO | disclosed |
| US-8242169-B2 | Emulsion composition | SHOWA DENKO K.K. (JP) | 2012-08-14 | — | — | US | disclosed |
| US-20090252773-A1 | EMULSION COMPOSITION | SHOWA DENKO K.K. (JP) | 2009-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250205362-A1 | LIPID NANOPARTICLES | ECH1, C1R, SGMS1 | FFAR4 603/4885FFAR1 130/4885GPR84 1040/4885 |
| US-20090252773-A1 | EMULSION COMPOSITION | ALOX5, ALOX15, ALOX15B | FFAR4 27/4885FFAR1 23/4885GPR84 380/4885 |
| US-20250177559-A1 | BRANCHED LIPID CHARGE-ALTERING RELEASABLE TRANSPORTERS FOR NUCLEIC ACID DELIVERY | SLC27A1, SLC27A2, SLC7A1 | FFAR4 2185/4885FFAR1 1201/4885GPR84 1549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.